Notch Signaling in Developmental and Tumor Angiogenesis
Open accessThe DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Abstract
The discovery that Notch, a key regulator of cell fate determination, is functional in the vasculature has greatly improved our understanding of differentiation and specialization of vessels. Notch signaling has been proven to be critical for arterial specification, sprouting angiogenesis, and vessel maturation. In newly forming vascular sprouts, Notch promotes the distinction between the leading "tip" endothelial cell and the growing "stalk" cell, the endothelial cells that eventually form a new capillary. Notch signaling has also been implicated in vessel stability by regulating vascular mural cell function. More recently, macrophages carrying an activated Notch have been implicated in shaping the course of new sprout formation. Tumor vessels abide by similar principles and use Notch signaling in similar ways. An exciting discovery, made by several researchers, shows that blocking Notch function in tumor vasculature provides a means by which to suppress tumor growth. The authors discuss the developmental and physiological role of Notch in the vasculature and apply this knowledge to an overview of how Notch targeting in the tumor environment can affect tumor angiogenesis and growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notch signaling plays a key role in determining cell fate and regulating embryonic as well as tumor angiogenesis [132, 133].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986 · cited 1×
“Several studies demonstrate that VEGF-A is overexpressed in many human tumors.(93) Therefore, it is not surprising that inhibition of angiogenesis and development of the VEGF blockade have been considered an attractive strategy to treat human cancer (Table 1).”
BackgroundSorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060655 · Cited by 4,802
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Kopan, R., & Ilagan, M. X. G. (2009) · Cell · doi:10.1016/j.cell.2009.03.045 · Cited by 3,643 · cited 1×
“At the cell surface, Notch is presented as an extracellular and intracellular heterodimeric receptor held together by noncovalent bonds.(3) Ligand binding to the extracellular peptide alters the receptor confirmation, leading to 2 proteolytic cleavages.”
BackgroundHeterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287 · cited 1×
“To describe the diversity of their activation states and function, a simplified paradigm of macrophage polarization toward an M1 “classic” or M2 “alternative” activation state is useful.(71) M1 macrophages are induced in response to lipopolysaccharide (LPS) and interferon-gamma (IFN-γ) and produce inducible nitric oxi…”
BackgroundVEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302047 · Cited by 2,894
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Research works printed but not linked: 2
- [39]39. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol. 1995;11:73-91 [DOI] [PubMed] [Google Scholar]
- [128]128. Sawyer TK. AILERON Therapeutics. Chem Biol Drug Des. 2009;73(1):3-6 [DOI] [PubMed] [Google Scholar]
Cited by
Items 101–142 of 142
Wedemeyer, M. A., Ding, T., Garfinkle, E. A. R., Westfall, J. J., Navarro, J. B., Gonzalez, M. E. H., Varga, E. A., Witman, P. M., Mardis, E. R., Cottrell, C. E., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-72167-8 · Cited by 11
MiR-34a and endothelial biology
Li, Q., & Zhang, Q. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121976 · Cited by 9
Bisen, S., Verma, S. K., Mukhopadhyay, C. S., & Singh, N. K. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01279-y · Cited by 10
“Our study revealed that IL-33 99 – 270 signi fi cantly”
BackgroundPaneerselvan, N., & Ragunathan, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.032 · Cited by 10
Niapour, A., Miran, M., Seyedasli, N., & Norouzi, F. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-23510-x · Cited by 8
“Notch indirectly inhibits VEGFR2 expression via HEY2 induction, whereas Notch activation induces VEGFR1 at the mRNA and protein levels (Kofler et al. 2011).”
BackgroundChang, L., Nguyen, V., Nguyen, A. T., Scott, M., & James, A. W. (2015) · Medical Oncology · doi:10.1007/s12032-015-0651-6 · Cited by 8
Tsuruda, T., Sato, Y. Z., Tomita, M., Tanaka, H., Hatakeyama, K., Otsu, M., Kawano, A., Nagatomo, K., Yoshikawa, N., Ikeda, R., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.833649 · Cited by 7
“NOTCH signaling stimulates to tumor angiogenesis (24), while it inhibits the lymphatic vessel sprouting induced by vascular endothelial growth factor (25).”
BackgroundVenkatakrishnan, G., & Parvathi, V. D. (2022) · Medical Oncology · doi:10.1007/s12032-022-01810-z · Cited by 6
“Results of a study investigating the potency of VEGF effectors when supplied (via adenovirus gene transfer in rabbit hindlimb skeletal muscle) to skeletal muscle showed that both VEGF-A and VEGF-D played a role in generating an angiogenic response, indicated by a significant enlargement in microvessels.[44].”
BackgroundGupta, S. D., & Ta, M. (2024) · Scientific Reports · doi:10.1038/s41598-023-51079-z · Cited by 6
“Though Notch signaling is primarily known to play a vital role in the determination of cell fate, reports have also suggested its roles in promoting angiogenesis and vasculogenesis 18 .”
Role of EGFL7 in human cancers: A review
de Oliveira, C., Gonçalves, P. G., & Bidinotto, L. T. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31084 · Cited by 7
Shawber, C. J., Brown‐Grant, D., Wu, T., Kitajewski, J., & Douglas, N. C. (2019) · Biology Open · doi:10.1242/bio.037721 · Cited by 7
“TheNotch pathway regulates cell fate, cellular growth and invasion via direct cell-to-cell contact (Cuman et al., 2014; Kofler et al., 2011).”
BackgroundLi, R., Wang, W., Qiu, X., He, M., Tang, X., & Zhong, M. (2023) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2023.2264447 · Cited by 7
“It has been documented that POSTN regulates Notch signaling [22], which is pivotal for vasculature formation and maturation [23].”
BackgroundThe heterogeneity of NOTCH1 to tumor immune infiltration in pan-cancer
Duan, X., Wu, R., Zhang, M., Li, K., Yu, L., Sun, H., Hao, X., & Wang, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-79883-1 · Cited by 6
Exploring the molecular role of endostatin in diabetic neuropathy
Mukherjee, T., Behl, T., Sehgal, A., Bhatia, S., Singh, H., & BUNGAU, S. G. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06205-3 · Cited by 5
Yuwen, Y., Wang, X., Liu, J., Liu, Z., & Zhu, H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20777 · Cited by 5
An integrated analysis revealing the angiogenic function of TP53I11 in tumor microenvironment
Bai, W., Ren, J.-S., Li, K., & Jiang, Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29504 · Cited by 4
“To validate these hypotheses, initially, we utilized publicly accessible data from the GEO database (GSE98060) [30].”
Secord, A. A., & Siamakpour‐Reihani, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803741-6.00005-7 · Cited by 4
Targeting AMPK signaling in diabetic wounds facilitates the healing process
Roy, K., & Gorain, B. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104511 · Cited by 3
Martínez-Gascueña, P., Nueda, M., & Baladrón, V. (2026) · Cells · doi:10.3390/cells15050468 · Cited by 5
“Because NOTCH inhibition also remodels tumor vasculature [231,232], combinations with radiation or chemotherapy require careful timing.”
Blood Vessels in the Brain: A Signaling Hub in Brain Tumor Inflammation
Guérit, S., & Liebner, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-45514-3_11 · Cited by 3
Maintaining the Plexus: SYNJ2BP as a Novel Regulator of Angiogenesis
Mleynek, T., & Li, D. (2013) · Circulation Research · doi:10.1161/circresaha.113.302600 · Cited by 3
“Examples of this can be seen in vascular diseases, such as CADASIL, and in tumor growth.(3,4)”
BackgroundDeciphering the Angiogenic Switch: The Role of miRNAs in Breast Cancer
El‐Moaty, H. I. A., Doghish, A. S., Aly, S. H., Abd‐Elmawla, M. A., Tabaa, M. M. E., Rizk, N. I., Elesawy, A. E., Mageed, S. S. A., Mohammed, O. A., Elkhawaga, S. Y., et al. (2026) · IUBMB Life · doi:10.1002/iub.70102 · Cited by 2
Bashir, S., Cai, C. L., Marcelino, M., Aranda, J. V., & Beharry, K. D. A. (2024) · Pharmaceuticals · doi:10.3390/ph17030381 · Cited by 2
Sen, P., & Ghosh, S. S. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400059 · Cited by 2
Zhang, Z., Zhao, R., Wu, X., Ma, Y., & He, Y. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13412 · Cited by 4
“VeGF can stimulate the notch pathway, which can stimulate the expression of VeGF‑a through a feedback loop (86,87).”
Angiogenesis and Angiogenesis Inhibitors in Brain Tumors
Taslimi, S., & Das, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812100-9.00027-9 · Cited by 6
Vascular Modulatory Functions of Macrophages
Keklikoglou, I., & Palma, M. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1311-4_7 · Cited by 1
Quan, M., Liu, Y., Zhao, Y., Kay, M., Sun, K., Gavin, T. P., Pollock, R. E., Tao, W. A., & Kuang, S. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218538 · Cited by 1
Roles of Ubiquitination and SUMOylation in the Regulation of Angiogenesis
Rabellino, A., Andreani, C., & Scaglioni, P. P. (2019) · Caister Academic Press eBooks · doi:10.21775/9781912530120.18 · Cited by 1
Cell–Extracellular Matrix Adhesions in Vascular Endothelium
Valaris, S., & Kostourou, V. (2022) · Biology of extracellular matrix · doi:10.1007/978-3-031-19616-4_7 · Cited by 2
Out on the Fringe: Modulation of Notch Signaling by Glycosylation
Xu, K., & Egan, S. E. (2018) · Springer eBooks · doi:10.1007/978-1-4939-8859-4_4 · Cited by 1
An update on angiogenesis modulators with a potential therapeutic role
Philippa, C., Miroiu, R. I., SLEVIN, M. A., & Petcu, E. B. (2018) · Vascular Cell · doi:10.24238/13221-10-1-179 · Cited by 1
The process of endothelial cell migration during tumor angiogenesis
YuLin, L. I., Li, L., Xiao, S. O. N. G., Man, L. U., & MeiYu, S. U. N. (2013) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/972012-1859 · Cited by 1
Hydrogen peroxide modulation of angiogenic factors in tumor cells
de Sousa, A. M. J. G. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Pan, S., & Zhang, W. (2021) · Springer eBooks · doi:10.1007/978-981-16-1037-0_11
A novel antioxidant N-acetylcysteine Amide Alleviates Cyclophosphamide-induced Endothelial DamagePreprint
He, R., Zheng, W., Slof, T., Wärdell, E., Månsson‐Broberg, A., Norgren, S., Zhao, Y. H., & Hassan, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.07.647539
A novel vasculogenic mimicry-related nomogram predicts prognosis in hepatocellular carcinoma
Zhong, Y., Ding, F., Zhang, H., Zhang, D., Zhang, X., & Weng, S. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1431624
“…with our previous study, which identi fi ed NOTCH1 as an independent prognostic predictor for HCC. Directly in fl uencing vascular stability and vascular smooth muscle cell differentiation, NOTCH signaling is an essential component in the vascular development process (Ko fl er et al., 2011).”
Angiogenesis and angiogenesis inhibitors in brain tumors
Qazi, M. A., Taslimi, S., Das, S., & Lim-Fat, M. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27356-8.00037-1
CRISPR approaches: Modeling tumor-stroma interactions and their role in cancer progression
Raninga, B., & Gupta, P. S. (2026) · Gene Reports · doi:10.1016/j.genrep.2026.102569
Catita, J., Valença, A., López‐Luppo, M., Nacher, V., Bonet, A., Carretero, A., Jaramillo, P., Navarro, M., Faus, F., Mendes-Jorge, L., et al. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111177
O'Hea, H., Bourbonne, V., & Marignol, L. H. (2026) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2026.101268
Metadata
- Authors
- Kofler, N. M., Shawber, C. J., Kangsamaksin, T., Reed, H. O., Galatioto, J., & Kitajewski, J.
- Affiliations
- Columbia University Irving Medical Center (US)
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2011-10-06
- Volume
- 2
- Issue
- 12
- Pages
- 1106-1116
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- PMC
- PMC3411124
- OpenAlex
- W2140676103
- Cited by
- 142
- References
- 129
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 12 · 2023: 9 · 2022: 13 · 2021: 7 · 2020: 7 · 2019: 17 · 2018: 18 · 2017: 12 · 2016: 8 · 2015: 8 · 2014: 11 · 2013: 9
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Genes & Cancer (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL062454, F31HL090032)
- National Cancer Institute (R01CA136673)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007328)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- Notch signaling, angiogenesis, tumor angiogenesis, vascular development, arterial specification, sprouting angiogenesis, vessel maturation, vascular mural cells, macrophages, tumor vasculature, Notch inhibitors, tumor growth inhibition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.